Kuangli Bio-Tech Holdings Co., Ltd.

TWSE:6431 Stock Report

Market Cap: NT$1.1b

Kuangli Bio-Tech Holdings Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure5.8yrs

Recent management updates

Recent updates

Kuangli Bio-Tech Holdings Co., Ltd.'s (TWSE:6431) Shareholders Might Be Looking For Exit

Mar 22
Kuangli Bio-Tech Holdings Co., Ltd.'s (TWSE:6431) Shareholders Might Be Looking For Exit

We're Not Worried About Kuangli Photoelectric Technology's (TPE:6431) Cash Burn

Mar 31
We're Not Worried About Kuangli Photoelectric Technology's (TPE:6431) Cash Burn

Did Business Growth Power Kuangli Photoelectric Technology's (TPE:6431) Share Price Gain of 248%?

Feb 03
Did Business Growth Power Kuangli Photoelectric Technology's (TPE:6431) Share Price Gain of 248%?

We Think Kuangli Photoelectric Technology (TPE:6431) Can Easily Afford To Drive Business Growth

Dec 09
We Think Kuangli Photoelectric Technology (TPE:6431) Can Easily Afford To Drive Business Growth

CEO

Kuangli Bio-Tech Holdings has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Qinglian Zhang
Manager & Director5.8yrsno data1.89%
NT$ 20.6m
Ming Tang Cai
Independent Directorno datano datano data
Shifang Qiu
Independent Director5.8yrsno datano data
Qinghui Zhang
Director5.8yrsno datano data
Minzheng Liao
Director5.8yrsno datano data
Huixian Wang
Independent Director5.8yrsno datano data
Kuan-Tsong Chen
Chairman of the Boardno datano data0.0014%
NT$ 15.0k

5.8yrs

Average Tenure

Experienced Board: 6431's board of directors are considered experienced (5.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 20:42
End of Day Share Price 2025/01/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kuangli Bio-Tech Holdings Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution